Loop Diuretics in the Treatment of Hypertension

Overview

Journal Curr Hypertens Rep

Specialty Cardiology & Vascular Diseases

Date 2016 Mar 9

PMID 26951244

Citations 18

Authors

Line Malha

Samuel J Mann

Affiliations

Soon will be listed here.

Abstract

Loop diuretics are not recommended in current hypertension guidelines largely due to the lack of outcome data. Nevertheless, they have been shown to lower blood pressure and to offer potential advantages over thiazide-type diuretics. Torsemide offers advantages of longer duration of action and once daily dosing (vs. furosemide and bumetanide) and more reliable bioavailability (vs. furosemide). Studies show that the previously employed high doses of thiazide-type diuretics lower BP more than furosemide. Loop diuretics appear to have a preferable side effect profile (less hyponatremia, hypokalemia, and possibly less glucose intolerance). Studies comparing efficacy and side effect profiles of loop diuretics with the lower, currently widely prescribed, thiazide doses are needed. Research is needed to fill gaps in knowledge and common misconceptions about loop diuretic use in hypertension and to determine their rightful place in the antihypertensive arsenal.

Citing Articles

Structural basis for human NKCC1 inhibition by loop diuretic drugs.

Zhao Y, Vidossich P, Forbush B, Ma J, Rinehart J, De Vivo M EMBO J. 2025; 44(5):1540-1562.

PMID: 39875725 PMC: 11876703. DOI: 10.1038/s44318-025-00368-6.

A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide.

Dao K, Dhillon A, Uddin S, Eppanapally S, Lai H J Investig Med High Impact Case Rep. 2024; 12:23247096241300932.

PMID: 39568096 PMC: 11580096. DOI: 10.1177/23247096241300932.

Repurposing antihypertensive drugs for pain disorders: a drug-target mendelian randomization study.

Du K, Li A, Zhang C, Li S, Chen P Front Pharmacol. 2024; 15:1448319.

PMID: 39268473 PMC: 11390634. DOI: 10.3389/fphar.2024.1448319.

Hyponatremia in geriatric patients.

Djukic M, Grewe J, Kunz O, Gross O, Nau R Z Gerontol Geriatr. 2024; 58(1):40-45.

PMID: 39143233 DOI: 10.1007/s00391-024-02342-z.

Structural bases for Na-Cl cotransporter inhibition by thiazide diuretic drugs and activation by kinases.

Zhao Y, Schubert H, Blakely A, Forbush B, Smith M, Rinehart J Nat Commun. 2024; 15(1):7006.

PMID: 39143061 PMC: 11324901. DOI: 10.1038/s41467-024-51381-y.

References

Lambe R, Kennedy O, Kenny M, Darragh A . Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers. Eur J Clin Pharmacol. 1986; 31 Suppl:9-14. DOI: 10.1007/BF00541461. View

Loon N, Wilcox C, Unwin R . Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 1989; 36(4):682-9. DOI: 10.1038/ki.1989.246. View

Fortuno A, Muniz P, Ravassa S, Rodriguez J, Fortuno M, Zalba G . Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension. 1999; 34(1):138-43. DOI: 10.1161/01.hyp.34.1.138. View

Reyes A, Leary W . Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations. Cardiovasc Drugs Ther. 1993; 7 Suppl 1:29-44. DOI: 10.1007/BF00877956. View

Wulf N, Matuszewski K . Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity?. Am J Health Syst Pharm. 2013; 70(17):1483-94. DOI: 10.2146/ajhp120291. View

Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M . Anti-aldosteronergic effect of torasemide. Eur J Pharmacol. 1991; 205(2):145-50. DOI: 10.1016/0014-2999(91)90812-5. View

Ellison D . The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med. 1991; 114(10):886-94. DOI: 10.7326/0003-4819-114-10-886. View

Egan B, Basile J, Rehman S, Davis P, Grob 3rd C, Riehle J . Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009; 22(7):792-801. DOI: 10.1038/ajh.2009.63. View

Matzdorf C, Kurtz A, Hocherl K . COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys. Am J Physiol Renal Physiol. 2007; 292(6):F1782-90. DOI: 10.1152/ajprenal.00513.2006. View

10.

Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View

11.

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c2. View

12.

Byatt C, Millard P, Levin G . Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med. 1990; 83(11):704-8. PMC: 1292918. DOI: 10.1177/014107689008301111. View

13.

Brater D . Clinical pharmacology of loop diuretics. Drugs. 1991; 41 Suppl 3:14-22. DOI: 10.2165/00003495-199100413-00004. View

14.

Knauf H, Mutschler E . Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol. 1995; 26(3):394-400. DOI: 10.1097/00005344-199509000-00008. View

15.

McAdams DeMarco M, Maynard J, Baer A, Gelber A, Young J, Alonso A . Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study. Arthritis Rheum. 2011; 64(1):121-9. PMC: 3253199. DOI: 10.1002/art.33315. View

16.

Dupont A, Schoors D, Six R, Vanhaelst L . Antihypertensive efficacy of low dose torasemide in essential hypertension: a placebo-controlled study. J Hum Hypertens. 1988; 2(4):265-8. View

17.

Jackson W, Nellen M . Effect of frusemide on carbohydrate metabolism, blood-pressure, and other modalities. A comparison with chlorothiazide. Br Med J. 1966; 2(5509):333-6. PMC: 1943166. DOI: 10.1136/bmj.2.5509.333. View

18.

Taler S, Textor S, Augustine J . Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension. 2002; 39(5):982-8. DOI: 10.1161/01.hyp.0000016176.16042.2f. View

19.

Achhammer I, Metz P . Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs. 1991; 41 Suppl 3:80-91. DOI: 10.2165/00003495-199100413-00009. View

20.

Dunn C, Fitton A, Brogden R . Torasemide. An update of its pharmacological properties and therapeutic efficacy. Drugs. 1995; 49(1):121-42. DOI: 10.2165/00003495-199549010-00009. View